88777346 - CHIMERIC VIGOR

Information

  • Trademark
  • 88777346
  • Serial Number
    88777346
  • Filing Date
    January 29, 2020
    4 years ago
  • Transaction Date
    April 07, 2024
    8 months ago
  • Status Date
    August 28, 2023
    a year ago
  • Published for Opposition Date
    June 02, 2020
    4 years ago
  • Location Date
    December 28, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    RIRIE, VERNA BETH
  • Attorney Docket Number
    267218/CLTY-
    Attorney Name
    Camille M. Miller
    Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
4000
Mark Identification
CHIMERIC VIGOR
Case File Statements
  • GS0051: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
  • GS0011: Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
  • D10000: "CHIMERIC"
  • GS0421: Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing
Case File Event Statements
  • 8/28/2023 - a year ago
    41 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 8/28/2023 - a year ago
    40 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 12/30/2022 - a year ago
    39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/29/2022 - a year ago
    38 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 12/27/2022 - 2 years ago
    37 - SOU EXTENSION 5 FILED Type: EXT5
  • 12/27/2022 - 2 years ago
    36 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/29/2022 - 2 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/27/2022 - 2 years ago
    34 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 6/27/2022 - 2 years ago
    33 - SOU EXTENSION 4 FILED Type: EXT4
  • 6/27/2022 - 2 years ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/1/2022 - 2 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/30/2021 - 2 years ago
    30 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/30/2021 - 2 years ago
    29 - SOU EXTENSION 3 FILED Type: EXT3
  • 12/30/2021 - 2 years ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/28/2021 - 3 years ago
    27 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 12/8/2021 - 3 years ago
    26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/16/2021 - 3 years ago
    25 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 6/29/2021 - 3 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/25/2021 - 3 years ago
    23 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/25/2021 - 3 years ago
    22 - SOU EXTENSION 2 FILED Type: EXT2
  • 6/25/2021 - 3 years ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/31/2020 - 3 years ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/29/2020 - 3 years ago
    19 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/29/2020 - 3 years ago
    18 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/29/2020 - 3 years ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/8/2020 - 4 years ago
    16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/8/2020 - 4 years ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/8/2020 - 4 years ago
    14 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/28/2020 - 4 years ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/2/2020 - 4 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/2/2020 - 4 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/13/2020 - 4 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/29/2020 - 4 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/28/2020 - 4 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/27/2020 - 4 years ago
    7 - ASSIGNED TO LIE Type: ALIE
  • 4/27/2020 - 4 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/27/2020 - 4 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/27/2020 - 4 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/17/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/4/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/1/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP